Group 1 - The core viewpoint of the article highlights the performance and valuation of Jianhui Information, which closed at 23.11 yuan with a PE ratio of 102.36 times, significantly higher than the industry average of 49.00 times [1][2] - Jianhui Information's total market capitalization is 3.143 billion yuan, ranking 37th in the medical services industry based on PE ratio [1][2] - As of March 31, 2025, Jianhui Information has 16,423 shareholders, an increase of 939 from the previous period, with an average holding value of 352,800 yuan per shareholder [1] Group 2 - The company's main business focuses on providing intelligent management solutions for the pharmaceutical and medical service industries, including smart pharmacy projects and logistics automation [1] - In the latest quarterly report for Q1 2025, Jianhui Information reported a revenue of 77.0622 million yuan, a year-on-year increase of 116.27%, while net profit was 3.4261 million yuan, a decrease of 34.65% [1] - The gross profit margin for the company stands at 37.17% [1]

Company Overview - The company, Shanghai Jianhui Information Technology Co., Ltd., focuses on providing intelligent management solutions for the pharmaceutical and medical service industries [1] - Main products include smart pharmacy projects, intelligent central preparation centers, intelligent drug consumables management, logistics and mobile robotics projects, maintenance services, and other business revenues [1] Financial Performance - For Q1 2025, the company reported revenue of 77.06 million yuan, a year-on-year increase of 116.27% [1] - Net profit for the same period was 3.43 million yuan, showing a year-on-year decrease of 34.65% [1] - The gross profit margin was reported at 37.17% [1] Market Position - The company's stock closed at 22.66 yuan, with a PE ratio of 100.37, marking a new low in 11 days [1] - The total market capitalization is 3.082 billion yuan [1] - In comparison to the industry, the average PE ratio for the medical services sector is 47.79, with a median of 59.03, placing the company at 38th in the industry ranking [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 16,423, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Jianhui Information, which closed at 19.96 yuan, up 4.56%, with a rolling PE ratio of 88.41, marking a new low in 20 days, and a total market capitalization of 2.715 billion yuan [1] - The average PE ratio for the medical services industry is 38.66, with a median of 38.36, positioning Jianhui Information at the 39th rank within the industry [1] - As of March 31, 2025, Jianhui Information had 16,423 shareholders, an increase of 939 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Jianhui Information specializes in providing products and services for intelligent management of pharmaceuticals in the medical services and pharmaceutical distribution sectors, with key products including smart pharmacy projects and intelligent drug management systems [1] - The company has implemented various intelligent drug management projects in over 800 hospitals across 29 provinces, autonomous regions, and municipalities, including prestigious institutions like Peking Union Medical College Hospital, enhancing its brand advantage [1] - In the latest quarterly report for Q1 2025, Jianhui Information reported revenue of 77.0622 million yuan, a year-on-year increase of 116.27%, while net profit was 3.4261 million yuan, reflecting a year-on-year decrease of 34.65%, with a gross profit margin of 37.17% [1]

上海健麾信息技术股份有限公司的主营业务为医疗服务和医药流通行业的药品智能化管理提供相应的产 品及服务。公司的主要产品是智慧药房项目、智能化静配中心项目、智能化药品耗材管理项目。公司已 于800余家医院实施了各类智能化药品管理项目，范围遍布29个省、自治区及直辖市，包括北京协和医 院在内的众多知名医疗服务机构均使用公司的产品，使公司的品牌优势不断积累。 最新一期业绩显示，2024年三季报，公司实现营业收入1.95亿元，同比-19.07%；净利润3205.15万元， 同比-56.71%，销售毛利率57.35%。 4月21日，健麾信息今日收盘18.69元，上涨1.25%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到141.18倍，总市值25.42亿元。 从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均46.70倍，行业中值48.76倍，健麾信息排 名第40位。 股东方面，截至2024年9月30日，健麾信息股东户数12211户，较上次增加1198户，户均持股市值35.28 万元，户均持股数量2.76万股。 序号股票简称PE(TTM)PE(静)市净率总市值(元)40健麾信息141.1842.362 ...

Group 1 - The core viewpoint of the articles highlights the performance and market position of Jianhui Information, which operates in the medical services and pharmaceutical distribution sector, showcasing its growth and challenges in the current market environment [1][2] - As of April 1, Jianhui Information's stock closed at 20.49 yuan, with a PE ratio of 154.78, significantly higher than the industry average of 52.86 [1][2] - The company has a total market capitalization of 2.787 billion yuan, ranking 40th in the medical services industry based on PE ratio [1][2] Group 2 - Jianhui Information reported a revenue of 195 million yuan for the third quarter of 2024, reflecting a year-on-year decrease of 19.07%, while net profit fell by 56.71% to 32.05 million yuan [1] - The company's gross profit margin stands at 57.35%, indicating its ability to maintain profitability despite declining revenues [1] - The company has implemented various intelligent drug management projects in over 800 hospitals across 29 provinces, enhancing its brand recognition and market presence [1]